Information Technology Security Incident

Click here for a notice about a data privacy incident at Capital Health.

Clinical Trials

Neuro-Oncology Clinical Research

The Center for Neuro-Oncology participates in, and develops, numerous research studies and clinical trials. The goal is to help provide greater understanding, develop new methods to detect and diagnose those diseases, and focus on innovative treatments that are not broadly available to patients.

Clinical trials offer patients some of the very latest in care while giving physicians and researchers the opportunity to study the safety and effectiveness of new treatments. Participation is voluntary.

Our experienced neuro-oncology team, carefully review study criteria, potential benefits, risks, and other considerations with eligible patients for enrollment into a clinical study. Once enrolled, our clinical research staff carefully monitors patients throughout the research trial and is available to answer questions.

Click here to learn more about our ongoing trials available at Capital Health Cancer Center.

 

TVAX: Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Study Information: NCT05685004
Sponsor: TVAX Biomedical
Principal Investigator: Michael Salacz, MD & Navid Redjal, MD, FAANS
Contact: Clinical Research at [email protected] or 609-537-5638

Observation or radiation therapy in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery

Study Information: NCT03180268
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-537-5638

Genomically-guided treatment trial in brain metastasis

Study Information: NCT03994796
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-537-5638

A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioblastoma With Elevated Mutational Burden

Study Information: NCT04145115
Sponsor: National Clinical Trials Network, NCI through collaborative groups
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-537-5638

The use of the ketogenic diet as an adjuvant to treatment of glioblastome multiforme

Study Information: NCT N/A
Sponsor: Capital Health System, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-537-5638

Molecular and biochemical characterization of malignant and metastatic brain tumors

Study Information: NCT N/A
Sponsor: Capital Health System, Inc. in collaboration with Princeton University and Rutgers University
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-303-6287

Assessing quality of life in adult neuro-oncology patients after CyberKnife or WBRT (Whole Brain Radiation Therapy), a prospective registry

Study Information: NCT N/A
Sponsor: Capital Health System, Inc.
Principal Investigator: Navid Redjal, MD, FAANS, Neurosurgeon
Contact: Clinical Research at [email protected] or 609-394-4130